文献速递神经肿瘤功能神经外科

颅内脑膜瘤手术后的长期癫痫控制及预测因素:一项基于人群的研究

Long-term control and predictors of seizures in intracranial meningioma surgery: a population-based study.
PubMed 文献 · Acta Neurochir (Wien) · 2018-01-11

这项回顾性研究纳入2006至2008年在卡罗林斯卡大学医院手术的113例新诊断颅内脑膜瘤成人患者,随访至2015年底,分析术前术后癫痫发作的长期控制、抗癫痫药物处方及预测因素。术前21/113(18.6%)有癫痫发作,其中8/21(38.1%)术后长期无发作;术后13例(14%)出现新发癫痫。肿瘤直径≥3.5 cm是术前癫痫的危险因素(OR 3.83,95%CI 1.14-12.87)。

要点

  • 术前癫痫发生率为18.6%(21/113),其中38.1%(8/21)术后长期无发作。
  • 术后新发癫痫发生率为14%(13例)。
  • 肿瘤直径≥3.5 cm与术前(OR 3.83)和术后(OR 2.65)癫痫风险相关。

核心结论

  • 癫痫在颅内脑膜瘤手术前后均常见,约三分之一的术前癫痫患者术后长期随访中无发作,14%的患者术后出现新发癫痫。
  • 较大的肿瘤尺寸、无头痛和非颅底位置与术前癫痫相关,而肿瘤大小和术前癫痫与术后癫痫相关。

研究设计与样本

  • 回顾性研究,纳入2006年至2008年在卡罗林斯卡大学医院手术的113例连续成人(>18岁)新诊断脑膜瘤患者,随访至2015年底。
  • 通过病历回顾和电话访谈获取癫痫发作和抗癫痫药物处方数据,应用逻辑回归和生存分析识别术前和术后癫痫的危险因素。

主要发现

  • 术前癫痫发生率为18.6%(21/113),其中38.1%(8/21)术后变为无发作。
  • 术后新发癫痫发生率为14%(13例)。
  • 术前癫痫的危险因素:肿瘤直径≥3.5 cm(OR 3.83,95%CI 1.14-12.87);头痛(OR 0.19,95%CI 0.05-0.76)和颅底肿瘤位置(OR 0.14,95%CI 0.04-0.44)降低术前癫痫风险。
  • 术后癫痫与肿瘤直径≥3.5 cm(OR 2.65,95%CI 1.06-6.62)和术前癫痫史(OR 3.50,95%CI 1.55-7.90)相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this retrospective study was to investigate the long-term seizure control and antiepileptic drug (AED) prescriptions, as well as identifying predictors of seizure(s) before and after surgery in a population-based cohort of operated intracranial meningioma patients. METHODS: A total of 113 consecutive adult (> 18 years old) patients with newly diagnosed meningioma operated at the Karolinska University Hospital between 2006 and 2008 were included and followed up until the end of 2015. Data on seizure activity and AED prescriptions were obtained through chart review and telephone interview. Logistic regression and survival analysis were applied to identify risk factors for pre- and postoperative seizures. RESULTS: A total of 21/113 (18.6%) patients experienced seizures before surgery of which 8/21 (38.1%) went on to become seizure-free after surgery. Thirteen (14%) patients experienced new-onset seizures after surgery. The regression analysis revealed tumor diameter ≥ 3.5 cm as a risk factor for preoperative seizures (OR 3.83, 95% CI 1.14-12.87). Presence of headache (OR 0.19, 95% CI 0.05-0.76) and skull base tumor location (OR 0.14, 95% CI 0.04-0.44) decreased the risk of preoperative seizures. Postoperative seizures were associated with tumor diameter ≥ 3.5 cm (OR 2.65, 95% CI 1.06-6.62) and history of preoperative seizures (OR 3.50, 95% CI 1.55-7.90). CONCLUSION: Seizures are common before and after intracranial meningioma surgery. Approximately one third of patients with preoperative seizures become seizure-free on long-term follow-up after surgery, while 14% experienced new-onset seizures after surgery. Larger tumor size, absence of headache, and non-skull base location were associated with preoperative seizures, while tumor size and preoperative seizures were associated with postoperative seizures.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Xue H, Sveinsson O, Bartek J, et al. Long-term control and predictors of seizures in intracranial meningioma surgery: a population-based study. Acta Neurochir (Wien). 2018. PMID: 29327143. doi:10.1007/s00701-017-3434-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。